106 related articles for article (PubMed ID: 30266033)
1. Generation of human induced pluripotent stem cell lines (hiPSC) from one bipolar disorder patient carrier of a DGKH risk haplotype and one non-risk-variant-carrier bipolar disorder patient.
Palladino VS; Subrata NOC; Geburtig-Chiocchetti A; McNeill R; Hoffmann P; Reif A; Kittel-Schneider S
Stem Cell Res; 2018 Oct; 32():104-109. PubMed ID: 30266033
[TBL] [Abstract][Full Text] [Related]
2. DGKH genetic risk variant influences gene expression in bipolar affective disorder.
Kittel-Schneider S; Lorenz C; Auer J; Weißflog L; Reif A
J Affect Disord; 2016 Jul; 198():148-57. PubMed ID: 27016658
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Generation of human induced pluripotent stem cell lines (hiPSC) from one bipolar disorder patient carrier of a DGKH risk haplotype and one non-risk-variant-carrier bipolar disorder patient" [Stem Cell Res. 2018 Oct;32:104-109. doi: 10.1016/j.scr.2018.09.008. Epub 2018 Sep 17].
Palladino VS; Subrata NOC; Geburtig-Chiocchetti A; McNeill R; Hoffmann P; Reif A; Kittel-Schneider S
Stem Cell Res; 2019 Apr; 36():101419. PubMed ID: 30898465
[No Abstract] [Full Text] [Related]
4. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
5. Generation of 5 induced pluripotent stem cell lines, LUMCi007-A and B and LUMCi008-A, B and C, from 2 patients with Huntington disease.
van der Graaf LM; Gardiner SL; Tok M; Brands T; Boogaard MW; Pepers BA; Eussen B; de Klein A; Aziz NA; Freund C; Buijsen RAM; van Roon-Mom WMC
Stem Cell Res; 2019 Aug; 39():101498. PubMed ID: 31326748
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant-Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A).
Brookhouser N; Zhang P; Caselli R; Kim JJ; Brafman DA
Stem Cell Res; 2018 Oct; 32():145-149. PubMed ID: 30296667
[TBL] [Abstract][Full Text] [Related]
7. Effect of variation in diacylglycerol kinase η (DGKH) gene on brain function in a cohort at familial risk of bipolar disorder.
Whalley HC; Papmeyer M; Romaniuk L; Johnstone EC; Hall J; Lawrie SM; Sussmann JE; McIntosh AM
Neuropsychopharmacology; 2012 Mar; 37(4):919-28. PubMed ID: 22048461
[TBL] [Abstract][Full Text] [Related]
8. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
9. Establishment of TUSMi004-A, an induced pluripotent stem cell (iPSC) line from a 32-year old Chinese Han patient with Obsessive-Compulsive Disorder (OCD).
Wang Y; Kang C; Yu H; Fen J; Ma X; Lei Y; Zhao J
Stem Cell Res; 2018 Oct; 32():83-86. PubMed ID: 30223146
[TBL] [Abstract][Full Text] [Related]
10. Generation of a human induced pluripotent stem cell line (CSC-42) from a patient with sporadic form of Parkinson's disease.
Savchenko E; Marote A; Russ K; Collin A; Goldwurm S; Roybon L; Pomeshchik Y
Stem Cell Res; 2018 Mar; 27():78-81. PubMed ID: 29334629
[TBL] [Abstract][Full Text] [Related]
11. Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population.
Mura M; Pisano F; Stefanello M; Ginevrino M; Boni M; Calabrò F; Crotti L; Valente EM; Schwartz PJ; Brink PA; Gnecchi M
Stem Cell Res; 2019 Aug; 39():101510. PubMed ID: 31398660
[TBL] [Abstract][Full Text] [Related]
12. Generation of three human induced pluripotent stem cell (hiPSC) lines derived from one Gaucher disease patient with Parkinson's disease and two unrelated Parkinson's disease patients with GBA mutations.
Tofoli FA; Chien HF; Barbosa ER; Pereira LV
Stem Cell Res; 2019 Aug; 39():101519. PubMed ID: 31401455
[TBL] [Abstract][Full Text] [Related]
13. Generation of human induced pluripotent stem cell lines from human dermal fibroblasts using a non-integration system.
Uhm KO; Kim SJ; Jo EH; Go GY; Choi HY; Im YS; Ha HY; Kim JH; Koo SK
Stem Cell Res; 2017 May; 21():13-15. PubMed ID: 28677527
[TBL] [Abstract][Full Text] [Related]
14. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant.
Brookhouser N; Zhang P; Caselli R; Kim JJ; Brafman DA
Stem Cell Res; 2017 Dec; 25():266-269. PubMed ID: 29246571
[TBL] [Abstract][Full Text] [Related]
16. Generation of human-induced pluripotent stem cells from burn patient-derived skin fibroblasts using a non-integrative method.
Fu S; Ding J; Liu D; Huang H; Li M; Liu Y; Tu L; Liu D
Int J Mol Med; 2018 Jan; 41(1):87-94. PubMed ID: 29115387
[TBL] [Abstract][Full Text] [Related]
17. Viral-free generation and characterization of a human induced pluripotent stem cell line from dermal fibroblasts.
Engel M; Balez R; Muñoz SS; Cabral-da-Silva MC; Stevens CH; Bax M; Do-Ha D; Sidhu K; Sachdev P; Ooi L
Stem Cell Res; 2018 Oct; 32():135-138. PubMed ID: 30278375
[TBL] [Abstract][Full Text] [Related]
18. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
19. Establishment of TUSMi005-A, an induced pluripotent stem cell (iPSC) line from a 32-year old Chinese Han patient with Bipolar Disorder (BD).
Wang Y; Fen Q; Yu H; Qiu H; Ma X; Lei Y; Zhao J
Stem Cell Res; 2018 Dec; 33():65-68. PubMed ID: 30316949
[TBL] [Abstract][Full Text] [Related]
20. Generation of a human induced pluripotent stem cell (iPSC) line from a 51-year-old female with attention-deficit/hyperactivity disorder (ADHD) carrying a duplication of SLC2A3.
Jansch C; Günther K; Waider J; Ziegler GC; Forero A; Kollert S; Svirin E; Pühringer D; Kwok CK; Ullmann R; Maierhofer A; Flunkert J; Haaf T; Edenhofer F; Lesch KP
Stem Cell Res; 2018 Apr; 28():136-140. PubMed ID: 29477591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
